quantisnow
FeedTopReportsPricing
⌘K
Live feed
21:08:19·77d
INSIDERFiling
Kyntra Bio Inc. logo

SEC Form 4 filed by CEO Wettig Thane

KYNB· Kyntra Bio Inc.
Health Care
Original source

Companies

  • KYNB
    Kyntra Bio Inc.
    Health Care

Related

  • SEC14d
    Kyntra Bio Inc. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
  • PR15d
    Kyntra Bio to Present at the 25th Annual Needham Virtual Healthcare Conference
  • SEC38d
    SEC Form 10-K filed by Kyntra Bio Inc.
  • SEC38d
    Kyntra Bio Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
  • PR38d
    Kyntra Bio Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
  • INSIDER44d
    SEC Form 4 filed by Kyntra Bio Inc.
  • INSIDER44d
    SEC Form 4 filed by Kyntra Bio Inc.
  • PR45d
    Kyntra Bio to Report Fourth Quarter and Full Year 2025 Financial Results
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022